Probity Scientific Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 5.25 M
- Revenue Growth -1.81%
- Profit Growth -5239.40%
- Ebitda -465.75%
- Net Worth -571.88%
- Total Assets 35.24%
About Probity Scientific
Probity Scientific Private Limited (PSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 June 2012 and has a history of 12 years and seven months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹5.25 M.
Sushilkumar Sapate and Meena Sapate serve as directors at the Company.
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74220MH2012PTC232350
- Company No.
232350
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2012
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Probity Scientific?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushilkumar Sapate  | Director | 18-Jun-2012 | Current |
| Meena Sapate | Director | 04-Dec-2015 | Current |
Financial Performance of Probity Scientific.
Probity Scientific Private Limited, for the financial year ended 2015, experienced Minor drop in revenue, with a 1.81% decrease. The company also saw a substantial fall in profitability, with a 5239.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 571.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Probity Scientific?
In 2015, Probity Scientific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.25 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2013 | Corporation Bank | ₹5.25 M | Open |
How Many Employees Work at Probity Scientific?
Unlock and access historical data on people associated with Probity Scientific, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Probity Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Probity Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
